DUREZOL
Total Payments
$801,041
Transactions
10,074
Doctors
4,618
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $922.67 | 27 | 26 |
| 2019 | $241,851 | 3,179 | 1,955 |
| 2018 | $171,500 | 3,460 | 2,136 |
| 2017 | $386,767 | 3,408 | 2,252 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $308,303 | 95 | 38.5% |
| Food and Beverage | $199,871 | 9,785 | 25.0% |
| Space rental or facility fees (teaching hospital only) | $172,100 | 61 | 21.5% |
| Consulting Fee | $73,930 | 21 | 9.2% |
| Travel and Lodging | $46,837 | 112 | 5.8% |
Top Doctors Receiving Payments for DUREZOL — Page 185
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Ophthalmology | Dallas, TX | $4.49 | 1 |
| , M.D | Ophthalmology | Santa Ana, CA | $4.30 | 1 |
| , OD | Optometrist | Phoenix, AZ | $4.14 | 1 |
| , O.D | Optometrist | Tucson, AZ | $3.90 | 1 |
| , MD | Ophthalmology | Lake Charles, LA | $3.85 | 1 |
| , MD | Ophthalmology | Los Angeles, CA | $3.69 | 1 |
| , M.D | Ophthalmology | Metairie, LA | $3.59 | 2 |
| , MD | Ophthalmology | Danbury, CT | $3.10 | 1 |
| , M.D | Ophthalmology | Burbank, CA | $3.00 | 1 |
| , MD | Ophthalmology | Allentown, PA | $2.96 | 2 |
| , MD, PHD | Retina Specialist | Philadelphia, PA | $2.73 | 1 |
| , MD | Ophthalmology | Smithtown, NY | $2.68 | 1 |
| , MD | Ophthalmology | Smithtown, NY | $2.68 | 1 |
| , MD | Interventional Cardiology | Louisville, KY | $2.19 | 1 |
| , M.D | Ophthalmology | Bala Cynwyd, PA | $1.91 | 1 |
| , M.D | Ophthalmology | Lake Charles, LA | $1.78 | 1 |
| , O.D | Optometrist | Louisville, KY | $1.58 | 1 |
| , O.D | Optometrist | Edmond, OK | $1.31 | 1 |
| , M.D | Ophthalmology | Lexington, KY | $0.78 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $801,041
- Total Doctors 4,618
- Transactions 10,074
About DUREZOL
DUREZOL is a drug associated with $801,041 in payments to 4,618 healthcare providers, recorded across 10,074 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharmaceuticals Corporation.
Payment data is available from 2017 to 2020. In 2020, $922.67 was paid across 27 transactions to 26 doctors.
The most common payment nature for DUREZOL is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($308,303, 38.5% of total).